Skip to main content

Advertisement

Table 1 Clinical and pathological features of samples included in the study

From: Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation

  TACE (n = 16) No-TACE (n = 23) P value
Age (years) 56(48–68) 55(45–68) 0.363
Gender (F/M) 2/14 5/18 0.460
AFP (ng/ml) 660(3–7245) 382(3–2809) 0.114
Tumor Num. (Single/Multiple) 8/8 14/9 .0.365
Largest Tumor size Mean (range) (mm) 38 (20–76) 29(3–60) 0.069
Differentiation    0.156
Well 1 7  
Moderately 12 14  
Poor 3 2  
TNM Stage    0.365
I 8 14  
II 8 9